lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
10 rows where filing_uuid = "b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2205522 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f | Q3 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 1331 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2018 | third_quarter | TAX | Advocate against H.R. 1150, the Tanning Tax Repeal Act of 2017, and S. 2600, the Tanning Tax Repeal act of 2018, to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S.85/H.R. 394, Restoring Access to Medication Act and H.R. 6199, the Restoring Access to Medication and Modernizing Health Savings Accounts Act of 2018. Advocate against the inclusion of the repeal of the excise tax on indoor tanning services in the Save American Workers Act (H.R. 3798). | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 500000 | 0 | 0 | 2018-10-22T11:50:44.917000-04:00 | |
| 2205523 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f | Q3 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 1331 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2018 | third_quarter | HCR | Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act and to protect and preserve the use of compounded pharmaceuticals in the physician office prior to receipt of a patient prescription. Lobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting. Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Lobby members of Congress to support H. Res. 282 to encourage proper sun safety practices for youth under care of schools and camps. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2871, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077, Restoring Patients Voice Act. Support H.R. 1316, Prescription Drug Price Transparency Act. Support H.R. 2051, Fair Access for Safe and Timely Generics Act. Support H.R. 2212/S. 974, Creating and Restoring Equal Access to Equivalent Samples Act. Support H.R. 2999, Patients Access to Treatments Act. Support H.R. 3928, the Truth in Healthcare Marketing Act of 2017. Support S. 637, C-THRU Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act. Support S. 2553, Know the Lowest Prices Act. Support S. 2554, Patient Right to Know Drug Prices Act. Support H.R. 5958, Phair Pricing Act. Support H.R. 5343, Prescription Transparency Act. Support H.R. 6689/S. 3368, Ensuring Lasting Smiles Act. Advocate for relief for from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Support H.R. 4841/H.R. 5773/Section 6062 of H.R. 6 (SUPPORT for Patients & Communities Act), Standardizing Electronic Prior Authorization for Safe Prescribing Act and S. 2908, Electronic Prior Authorization in Medicare Part D Act. Support sunscreen related provisions… | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 500000 | 0 | 0 | 2018-10-22T11:50:44.917000-04:00 | |
| 2205524 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f | Q3 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 1331 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2018 | third_quarter | DEF | Support funding for Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD) in the Fiscal Year 2019 (FY19) Defense Appropriations bill (H.R. 6157, S. 3159). Support dedicated Melanoma research funding, outside of the Peer-Reviewed Cancer Research Program, at the DoD (H.R. 6157). | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 500000 | 0 | 0 | 2018-10-22T11:50:44.917000-04:00 | |
| 2205525 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f | Q3 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 1331 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2018 | third_quarter | VET | Advocate for access to dermatological procedures for veterans through the Veterans Choice Program, included in the VA MISSION Act (Public Law No: 115-182). | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 500000 | 0 | 0 | 2018-10-22T11:50:44.917000-04:00 | |
| 2205526 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f | Q3 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 1331 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2018 | third_quarter | MMM | Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage. Advocate for Congressional support for relief from Medicare regulations under Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110), including the Quality Payment Program (QPP) and specifically the development of advanced alternative payment models (APMs) and implementation of the Merit-Based Incentive Payment System (MIPS). Advocate for increased funding and reforms to Graduate Medical Education. Advocate for a new study on physician shortage to be conducted by the Health Resources and Services Administration. Lobby members of Congress regarding improvements to Health Information Technology implementation. Support provisions to allow Medicare Advantage plans to include telehealth as a benefit. Advocate for improving disease management and care coordination for patients with chronic diseases. Support preservation of the In-Offices Ancillary Services Exemption (IOASE) under Stark Law regarding physician self-referral and oppose repeal of the in-office ancillary and physician services exception. Advocate regarding possible changes to IOASE and Stark Law relative to implementation of Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110) Support H.R. 4206/S.2051 Medicare Care Coordination Improvement Act of 2017 Advocate for Congressional support for relief from Medicare regulations under Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110), including the Quality Payment Program (QPP) and specifically the development of advanced alternative payment models (APMs) and implementation of the Merit-Based Incentive Payment System (MIPS). Oppose elimination of a Merit-Based Incentive Payment System. Advocate allowing further appeals process within the Quality Payment Program. Advocate against H.R. 2066, Promoting Integrity in Medicare Act of 2017. Advocate for relief for from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Support H.R. 4841/H.R.… | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 500000 | 0 | 0 | 2018-10-22T11:50:44.917000-04:00 | |
| 2205527 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f | Q3 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 1331 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2018 | third_quarter | BUD | Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality, and Food and Drug Administration in FY19 Labor/HHS/Education Appropriations (H.R. 6470/S. 3158; H.R. 6157). Advocate for The National Hansens Disease Program funding in FY19 Labor/HHS/Education Appropriations (H.R. 6470, S. 3158; H.R. 6157). Support funding for Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD) in the Fiscal Year 2019 (FY19) Defense Appropriations bill (H.R. 6157, S. 3159). Support dedicated Melanoma research funding, outside of the Peer-Reviewed Cancer Research Program, at the DoD (H.R. 6157). | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 500000 | 0 | 0 | 2018-10-22T11:50:44.917000-04:00 | |
| 2205528 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f | Q3 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 1331 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2018 | third_quarter | IMM | Support legislation, such as, S. 1615/ H.R. 3440 DREAM Act, which would enable those individuals eligible with Deferred Action for Childhood Arrivals status are able to continue their employment, education, training, and research. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 500000 | 0 | 0 | 2018-10-22T11:50:44.917000-04:00 | |
| 2205529 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f | Q3 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 1331 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2018 | third_quarter | PHA | Lobby members of Congress to conduct oversight of implementation of Public Law 113-54, the Drug Quality and Security Act and to protect and preserve the use of compounded pharmaceuticals in the physician office prior to receipt of a patient prescription. Lobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting. Support H.R. 2871, Preserving Patient Access to Compounded Medications Act. Support H.R. 1316, Prescription Drug Price Transparency Act Support S. 637, C-THRU Act. Support S. 2553, Know the Lowest Price Act. Support S. 2554, Patient Right to Know Drug Prices Act. Support H.R. 5958, Phair Pricing Act. Support H.R. 5343, Prescription Transparency Act. Support sunscreen related provisions in S. 2315, OTC Drug Safety, Innovation & Reform Act/H.R. 5333, OTC Monograph Safety, Innovation, & Reform Act. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 500000 | 0 | 0 | 2018-10-22T11:50:44.917000-04:00 | |
| 2205530 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f | Q3 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 1331 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2018 | third_quarter | MED | Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality, and Food and Drug Administration in FY19 Labor/HHS/Education Appropriations (H.R. 6470/S. 3158; H.R. 6157). Advocate for The National Hansens Disease Program funding in FY19 Labor/HHS/Education Appropriations (H.R. 6470, S. 3158; H.R. 6157). Support funding for Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD) in the Fiscal Year 2019 (FY19) Defense Appropriations bill (H.R. 6157, S. 3159). Support dedicated Melanoma research funding, outside of the Peer-Reviewed Cancer Research Program, at the DoD (H.R. 6157). Lobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting (H.R. 3268). Support maintaining the Prevention and Public Health Fund (PPHF). | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 500000 | 0 | 0 | 2018-10-22T11:50:44.917000-04:00 | |
| 2205531 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f | Q3 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 1331 | AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 2018 | third_quarter | TOR | Advocate for legislation to enact medical liability reforms. Support H.R. 1704, Accessible Care by Curbing Excessive lawSuitS (ACCESS) Act. Support H.R. 1215, Protecting Access to Care Act. Support H.R. 1876, Good Samaritans Health Professionals Act | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 500000 | 0 | 0 | 2018-10-22T11:50:44.917000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);